Assembly Biosciences, Inc.
ASMB
$32.87
-$2.41-6.83%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 125.12% | 121.11% | 153.52% | 31.30% | 54.77% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 125.12% | 121.11% | 153.52% | 31.30% | 54.77% |
| Cost of Revenue | 8.31% | 10.11% | 15.88% | 17.44% | 17.62% |
| Gross Profit | 143.85% | 123.31% | 127.32% | -1.31% | 10.40% |
| SG&A Expenses | 11.06% | 10.63% | 8.89% | -14.97% | -18.35% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.95% | 10.23% | 14.18% | 7.86% | 6.61% |
| Operating Income | 79.78% | 69.65% | 73.32% | 6.44% | 13.87% |
| Income Before Tax | 99.89% | 83.88% | 84.64% | 4.32% | 13.57% |
| Income Tax Expenses | -- | -- | -- | -117.31% | -117.31% |
| Earnings from Continuing Operations | 99.89% | 84.01% | 84.76% | 5.53% | 14.57% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 99.89% | 84.01% | 84.76% | 5.53% | 14.57% |
| EBIT | 79.78% | 69.65% | 73.32% | 6.44% | 13.87% |
| EBITDA | 79.98% | 69.83% | 73.53% | 6.35% | 13.68% |
| EPS Basic | 97.10% | 79.35% | 71.34% | 33.20% | 37.64% |
| Normalized Basic EPS | 97.10% | 79.14% | 71.09% | 32.30% | 36.97% |
| EPS Diluted | 97.10% | 79.35% | 71.34% | 33.20% | 37.64% |
| Normalized Diluted EPS | 97.10% | 79.14% | 71.09% | 32.30% | 36.97% |
| Average Basic Shares Outstanding | 133.09% | 108.10% | 86.51% | 50.81% | 34.67% |
| Average Diluted Shares Outstanding | 133.09% | 108.10% | 86.51% | 50.81% | 34.67% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |